Consistent approach investing in outstanding healthcare businesses by partnering with exceptional management teams to drive growth and create value.

Portfolios Archive - G Square Capital

London and Milan, 10 September 2026 – G Square Healthcare Private Equity LLP (“G Square”), a leading European private equity firm specialising exclusively in

London, 7 July 2026 – G Square Healthcare Private Equity LLP ("G Square") today announces the successful close of a £500 million single-asset continuation

London, 21 May 2026 – G Square Healthcare Private Equity LLP ("G Square") has successfully closed the sale of portfolio company Medadom to Verdane, BPI, and

20 March 2026 – G Square Healthcare Private Equity LLP (“G Square”) is pleased to share portfolio company Medadom (“Medadom” or the “Company”) has executed an

London, UK – 21 October 2025

Founder and CEO

Prior to joining G Square in 2016, Oliver had worked for a year at Rothschild’s Five Arrows Principal Investments in London and one year at Langholm Capital,

Leading healthcare sector specialists investing primarily across Europe since 2008

Building long-term value with the consideration of ESG factors in investment decisions.

G Square Capital invests in mid-cap healthcare companies primarily in Europe, focusing on four key areas.

The company provides contact details: an email, phone number, and office address in London, United Kingdom.

Leading healthcare private equity investor focusing on mid-market companies with a high potential for growth.

What Are Cookies

G Square Healthcare Private Equity LLP is a company registered in England and Wales with company number OC385628. G Square Healthcare Private Equity LLP is

G Square Healthcare Private Equity LLP – SFDR Notice G Square Healthcare Private Equity LLP (“G Square”) proactively manages operational risk, including ESG

G Square Healthcare Private Equity LLP